Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Aterian CTO sells over $8.8k in company stock

Published 16/03/2024, 12:04 pm
Updated 16/03/2024, 12:04 pm
© Reuters.

Aterian, Inc. (NASDAQ:ATER) Chief Technology Officer, Roi Zion Zahut, has recently sold a total of 20,082 shares of company stock, as per the latest SEC filings. The transaction, which took place on March 13, 2024, resulted in a total sale value of $8,836 at an average price of $0.44 per share.

The shares were sold in multiple transactions with prices ranging from $0.41 to $0.44. This sale was conducted to meet tax withholding obligations related to the vesting of restricted stock awards. Following the sale, Zahut continues to hold 1,301,840 shares of Aterian, Inc. stock.

Investors and stakeholders in Aterian, Inc. often monitor such transactions as they provide insights into executives' perspectives on the company's stock value. The sales and purchases of company stock by insiders can sometimes be indicative of their confidence in the firm's future prospects.

InvestingPro Insights

Aterian, Inc. (NASDAQ:ATER) has been navigating a challenging market environment, as reflected in the recent insider stock sale by CTO Roi Zion Zahut. A deeper dive into the company's financials and stock performance through InvestingPro reveals some critical insights:

With a market capitalization of just $28.48 million, Aterian's size reflects the impact of recent market conditions and internal performance issues. The company's revenue has seen a significant decline over the last twelve months as of Q1 2023, with a drop of 35.54%. This downturn is further accentuated by a quarterly revenue decline of 40.34% in Q1 2023. These figures suggest that Aterian is facing substantial headwinds in generating sales growth, a concern for investors evaluating the company's recovery prospects.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Moreover, Aterian's stock price has experienced a sharp fall of 29.14% over the last week, and a 20.53% decline over the past month. These movements highlight the stock's high volatility, which could be a point of caution for potential investors. The company's P/E ratio stands at -0.35, and when adjusted for the last twelve months as of Q1 2023, it further declines to -0.71, indicating that the market has significant reservations about Aterian's earnings potential.

InvestingPro Tips for Aterian provide additional context, noting that the company holds more cash than debt on its balance sheet, suggesting some level of financial stability. However, analysts are not optimistic about sales growth in the current year, and they do not anticipate the company will be profitable this year. These insights could be crucial for investors considering the company's future trajectory.

For those looking to delve deeper into Aterian's financials and stock performance, there are 16 additional InvestingPro Tips available at Investing.com/pro/ATER. To access these insights and more, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.